Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

     Professor Sir Mike Stratton and Dr Trevor Lawley
    7 November 2025

    Sanger scientists receive major grant to study rise of early onset colorectal cancer

    Wellcome Sanger Institute researchers, Professor Sir Mike Stratton and Dr Trevor Lawley, together with Dr Paul Brennan of the International Agency for Research on Cancer (IARC) have been awarded a significant grant, enabling their team to investigate the causes of early onset colorectal...

    Arecor logo
    5 November 2025

    Arecor enhances IP coverage for AT278 and Oral Delivery Technology

    Cambridge, UK - Arecor Therapeutics plc, the biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases, provides an update on the broadening of its IP position. ...

    DNA
    4 November 2025

    145 families receive a diagnosis with new genomic method

    Experts have developed a new method for identifying structural changes in DNA, providing insights for 145 families and highlighting the importance of incorporating these changes into clinical practice. ...

    A gynecologist is performing an early pregnancy ultrasound screening, for a young female lying on a medical bed.
    13 November 2025

    How clinics can optimise patient pathways in early pregnancy care

    In early pregnancy, time isn’t a luxury patients have. Clinical decisions depend on precise diagnostic information that will guide treatment, intervention, and reassurance for patients. However, many services still experience what can be termed ‘decision delay’: a critical lag between t...

    Pierre Arsène, Founder and CEO, Mursla Bio
    13 November 2025

    Mursla Bio collaborates with a leading global pharma company to advance biomarker-guided precision medicine in MASH

    Mursla Bio’s AI Precision Medicine Platform to inform drug development and patient stratification in metabolic liver diseaseCambridge, UK, and Boston MA, USA, 13 November 2025: Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and s...

    Abselion’s Tagged Protein Quantification Kit | His-tag
    10 November 2025

    Abselion launches His-tagged Protein Quantification Kit and Sensors for Amperia at PEGS Europe 2025

    Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins Broadens Amperia’s applications across recombinant protein research, screening, and developmentAbselion to showcase kit alongside Amperia platform at PEGS Eu...

    Henry Miller, Ph.D., Head of Machine Learning, Shift Bioscience
    11 November 2025

    Shift Bioscience publishes improved metric calibration framework for robust genetic perturbation modeling using AI Virtual Cells

    AI virtual cells outperform key baselines on well-calibrated metrics, challenging prior reports of poor model performance Foundational research reinforces the use of virtual cell models to accelerate target identification pipelinesCambridge, UK, 11 November 2025: Shift Bioscie...

    Dr Nicola Thompson, CEO, TRIMTECH Therapeutics and Dr Mike Hutton, SAB Member, TRIMTECH Therapeutics
    11 November 2025

    TRIMTECH Therapeutics appoints Dr Mike Hutton to Scientific Advisory Board

    ·       Industry leader brings deep expertise across neurodegenerative disease therapeutics development ·       Dr Hutton joins Prof. Alessio Ciulli FRS and Dr Adam Gilbert on SAB ...

    Oxitec
    10 November 2025

    Guardtech supporting malaria fight in East Africa with Cleancube Multi 11 lab

    The Suffolk-based design & build experts are providing an 11-bay portable shipping container laboratory for Oxitec’s malaria-fighting Friendly™ mosquito programme over in Djibouti ...

    Huge heating bills shouldn’t leave anyone out in the cold. Cambridgeshire Community Foundation’s CEO Michael O’Toole and President Julie Spence OBE QPM CStJ in Peterborough for the launch of the Surviving Winter Appeal
    10 November 2025

    Cambridgeshire Community Foundation launches its annual Surviving Winter Appeal to tackle fuel poverty

    Residents encouraged to donate their Winter Fuel Allowance if they don’t need it to help those most in need. ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 44
    • Page 45
    • Current page 46
    • Page 47
    • Page 48
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS